EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

PCSK9 and Lipid Metabolism: Genetic Variants, Current Therapies, and Cardiovascular Outcomes

Daniela Grejtakova iD, Iveta Boronova iD, Jarmila Bernasovska iD, Stefano Bellosta iD

Cardiovascular Drugs and Therapy · 2025-12 · 39 (6) · 1439-1451

DOI: 10.1007/s10557-024-07599-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 22.06.2024. Verfasst von Daniela Grejtakova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Genetics, Department of Biology, Faculty of Humanities and Natural Sciences, University of Presov, 17 November 1, Presov, 080…. Hauptthemen laut MEDLINE: Proprotein Convertase 9, Lipid Metabolism, Cardiovascular Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prešov University in Prešov.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proprotein convertase subtilisin/kexin type 9 ( PCSK9 ) plays a crucial role in the modulation of lipid metabolism as a critical negative regulator of hepatic low-density lipoprotein receptor (LDLR) levels and circulating low-density lipoprotein (LDL) clearance. Numerous gain-of-function (GOF) mutations in PCSK9 have been identified as causing familial hypercholesterolemia (FH) by reducing LDLR levels, and loss-of-function (LOF) mutations associated with a hypercholesterolemia phenotype protective against atherosclerosis. PCSK9 represents an example of successful translational research resulting in the identification of PCSK9 as a major drug target for a lipid-lowering therapy. To explore the genetic constitution of PCSK9 and its biologic role, in this review, we summarize the current evidence of clinically significant PCSK9 genetic variants involved in lipid metabolism as well as emphasize the importance of PCSK9 inhibition for the improvement of cardiovascular outcomes by conducting a meta-analysis of the available data on the incidence of cardiovascular disease events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proprotein Convertase 9Lipid MetabolismCardiovascular DiseasesHumansPCSK9 InhibitorsAnimalsAnticholesteremic AgentsGenetic VariationReceptors, LDL

Stichwörter der Autor:innen

PCSK9Cardiovascular eventsGenetic variantsLipoproteinsMeta-analysisPCSK9 inhibitors

Substanzen

Proprotein Convertase 9PCSK9 protein, humanPCSK9 InhibitorsAnticholesteremic AgentsReceptors, LDL

Autor:innen und Institutionen

  • Laboratory of Molecular Genetics, Department of Biology, Faculty of Humanities and Natural Sciences, University of Presov, 17 November 1, Presov, 08001, Slovakia. daniela.grejtakova@gmail.com.
  • Laboratory of Molecular Genetics, Department of Biology, Faculty of Humanities and Natural Sciences, University of Presov, 17 November 1, Presov, 08001, Slovakia.
  • Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università Degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy.

ORCID-Profile: Daniela Grejtakova, Iveta Boronova, Jarmila Bernasovska, Stefano Bellosta

Förderung

  • Prešov University in Prešov

Zitieren

APA

Grejtakova, D., Boronova, I., Bernasovska, J., & Bellosta, S. (2025). PCSK9 and Lipid Metabolism: Genetic Variants, Current Therapies, and Cardiovascular Outcomes. Cardiovascular Drugs and Therapy, 39(6), 1439-1451. https://doi.org/10.1007/s10557-024-07599-5

Vancouver

Grejtakova D, Boronova I, Bernasovska J, Bellosta S. PCSK9 and Lipid Metabolism: Genetic Variants, Current Therapies, and Cardiovascular Outcomes. Cardiovascular Drugs and Therapy. 2025;39(6):1439-1451. doi:10.1007/s10557-024-07599-5

BibTeX
@article{Grejtakova2025,
  author = {Grejtakova, Daniela and Boronova, Iveta and Bernasovska, Jarmila and Bellosta, Stefano},
  title = {PCSK9 and Lipid Metabolism: Genetic Variants, Current Therapies, and Cardiovascular Outcomes},
  journal = {Cardiovascular Drugs and Therapy},
  year = {2025},
  volume = {39},
  number = {6},
  pages = {1439--1451},
  doi = {10.1007/s10557-024-07599-5}
}
Kostenlos starten →